• Share
  • Add this to...
  • Favorites
  • Del.icio.us
  • Digg
  • Facebook
  • Google Bookmarks
  • Yahoo MyWeb
• 
• 
• 
• 

Center Participation for the U.S. Patient Survival Report

More data provides better research information and better ability to predict outcomes. Understanding this, the Center for International Blood and Marrow Transplant Research^® (CIBMTR) works diligently to provide data of bone marrow, peripheral blood, and umbilical cord blood transplants that are as complete as possible.

The CIBMTR provides these data to the U.S. Health Resources and Services Administration as part of the Stem Cell Therapeutic Outcomes Database contract. (This contract is mandated by the Stem Cell Therapeutic and Research Act of 2005, Public Law 109-129, and the Stem Cell Therapeutic and Research Reauthorization Act of 2010, Public Law 111-264.)

Although requirements to report data have changed during the period of 2003-2008, since 2008 U.S. transplant centers are required by Federal laws to report data to the CIBMTR for all patients receiving an allogeneic transplant (cells from a related or unrelated donor). However, reporting data for patients receiving an autologous transplant (cells from the patient) is not required.

The CIBMTR has collected data from the majority of the transplants performed at U.S. transplant centers from 2003 through 2008. Although not all transplants are reported to the CIBMTR, there are sufficient data to present accurate estimates of survival.

We would like to acknowledge and thank the following transplant centers for reporting data about transplants performed from January 1, 2003 through December 31, 2008.